Suchergebnisse - "Henry, Brandon M"

PubPharm (57)

41

Fujirebio Lumipulse SARS-CoV-2 antigen immunoassay : pooled analysis of diagnostic accuracy

enthalten in: Diagnosis (Berlin, Germany) | 2022

von Lippi, G. | Henry, B. | Adeli, K. | +1

42

Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination

enthalten in: Advances in laboratory medicine | 2022

von Lippi, G. | Salvagno, G. | Henry, B. | +3

43

Blood lactate concentration in COVID-19 : a systematic literature review

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Carpenè, G. | Onorato, D. | Nocini, R. | +4

44

Virucidal effects of mouthwashes or mouth rinses : a world of caution for molecular detection of SARS-CoV-2 in saliva

enthalten in: Diagnosis (Berlin, Germany) | 2022

von Lippi, G. | Nocini, R. | Henry, B. | +1

45

The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Salvagno, G. | Henry, B. | Pighi, L. | +3

46

Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19) : A Multicenter Prospective Cohort Study

enthalten in: Frontiers in medicine | 2022

von Henry, B. | Sinkovits, G. | Szergyuk, I. | +28

47

Updated picture of SARS-CoV-2 variants and mutations

enthalten in: Diagnosis (Berlin, Germany) | 2021

von Lippi, G. | Mattiuzzi, C. | Henry, B.

48

The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Salvagno, G. | Henry, B. | Lippi, G.

49

Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Salvagno, G. | Henry, B. | Pighi, L. | +3

CommentOn: Clin Chem Lab Med. 2021 Apr 14;59(8):1444-1452. - PMID 33855843

50

Clinical assessment of the Roche SARS-CoV-2 rapid antigen test

enthalten in: Diagnosis (Berlin, Germany) | 2021

von Salvagno, G. | Gianfilippi, G. | Bragantini, D. | +2